Changes inBRCA2Expression during Progression of the Cell Cycle
- 8 May 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 234 (1) , 247-251
- https://doi.org/10.1006/bbrc.1997.6544
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Low incidence of BRCA2 mutations in breast carcinoma and other cancersNature Genetics, 1996
- BRCA2 mutations in primary breast and ovarian cancersNature Genetics, 1996
- Mutation analysis in the BRCA2 gene in primary breast cancersNature Genetics, 1996
- Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer familiesNature Genetics, 1996
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosomeNature Genetics, 1992